09:54 AM EST - Oncolytics Biotech® Inc. : Announced that data from REO 024 will be presented at the 2018 Gastrointestinal Cancers Symposium sponsored by ASCO, January 18 – 20, 2018, in San Francisco. Oncolytics Biotech® Inc.
shares T.ONC are trading up $0.01 at $0.68.
